What are the side effects of Acalabrutinib?

Acalabrutinibis a kinase inhibitor indicated for the treatment of adult patients with mantle cell lymphoma (MCL) who have received at least one prior therapy. This indication received accelerated approval based on overall response rate. Continued approval for this indication may be contingent upon verification and characterization of clinical benefit in confirmatory trials. Also suitable for chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma(SLL) patients.

Acalabrutini(Acalabrutinib)What are the side effects?

Acalabrutini(Acalabrutinib)Common side effects includebleeding events (50%), bleeding, hematoma, atrial fibrillation, atrial flutter, reduced hemoglobin (46% ), thrombocytopenia(44%), neutropenia(36%), neutropenia(23%), anemia(11%), headache(39%), diarrhea(31%), nausea pan>(19%), abdominal pain(15%), constipation(15%), vomiting pan>(13%), bruises/petechiae/petechiae/Contusion(21%), rash(18%), myalgia(21%), second primary malignant tumor(11%), Skin cancer, Elevated creatinine, Nistaxis, Pneumonia, Fatigue (28%), Infection, etc.

Acalabrutinib isBruton tyrosine kinase(BTK) inhibitor. The molecular formula of acalabrutinib is C26H23N7O2, and its molecular weight is 465.51. The chemical name is4-{ 8-Amino-3-[(2S)-1-(Butan-2-Acenoyl pan>)pyrrolidine-2-yl]imidazo[1,5-a]pyrazine-1-yl)}-N-(pyridine-2-yl)benzamide. Generic drugs cost about six to seven thousand per box. If you want to get more high-quality information, you can contact Yaode, and Yaode will do its best to help you learn more about high-quality overseas drugs.